When and how to reverse Direct oral anticoagulants
Direct oral anticoagulants (DOACs) are indicated for the prevention of systemic embolism in selected patients with non-valvular atrial fibrillation and for the prevention and /or treatment of venous thromboembolism. Guidance on when and how to reverse DOACs is discussed.
Dr Simon McRae, Chairman, Australian Haemophilia Centre Directors Organisation, Consultant Haematologist SA Pathology, Royal Adelaide Hospital.
• Describe the actions that should be taken when a patient presents with bleeding associated with the new oral anticoagulants
• Understand perioperative management and other considerations